| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e1c56b88229114d57f1a0050eb922f6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 |
| filingDate |
1998-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27dd98b939634431043efdbd8f721c6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d14af2b67c910727b565771ed91ce044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65214d8be650d1cbeedcdb3b248d37af |
| publicationDate |
2003-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2216317-C2 |
| titleOfInvention |
Composition simethicone/anhydrous calcium phosphate |
| abstract |
FIELD: medicine, pharmacy. SUBSTANCE: invention relates to the development of novel medicinal preparations of semithicone. Anti-foaming semithicone preparation as an oral, solid, medicinal form is prepared from freely flowing granulated composition comprising mixture consisting of simethicone or bicalcium phosphate or their mixture and one or some pharmaceutically acceptable excipients wherein mixture simethicone/calcium phosphate represents homogenous granulated composition with particles size 1 000 micron, not above. Composition can contain additionally silicon dioxide or anhydrous calcium phosphate as an adsorbing agent. The development of preparation allows expanding assortment of effective antifoaming and meteorism-eliminating medicinal agents. EFFECT: valuable properties of composition. 9 cl, 1 tbl, 6 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2460340-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2696578-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11717515-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2602745-C2 |
| priorityDate |
1997-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |